Perbedaan ekpresi imunositokimia Thyroid Transcription Factor-1 (TTF-1) pada non small cell carcinoma dari sikatan bronkus kanker paru
DAFTAR RUJUKAN
1. Parkin M, Tyczynski JE, Boffetta P, Samet J, Shields P, Caporaso N. Lung cancer
epidemiology and etiology. In: Travis WD, Brambilla E, Müller-Hermelink HK, Harris CC.
(Eds). World Health Organization Classification of Tumours. Pathology and Genetics of
Tumours of the Lung, Pleura, Thymus and Heart. IARC Press Lyon; 2004.p.14-17
2. French CA. Respiratory Tract. In : Cibas ES, Ducatman BS.(eds). Cytology: Diagnostic
Principles Clinical Correlates. 3rd ed. Elsevier. Philadelphia. 2009; p.89-100
3. Gaur DS, Thapliyal NC, Kishore S, Pathak VP. Efficacy of broncho-alveolar lavage and
bronchial brush cytology in diagnosing lung cancers. Jurnal of Cytology. 2007; 24 (24): 73-7.
Diunduh pada tanggal 3 Pebruari 2010;12.16.PM
4. Lamb C. Bronchial washing, bronchoalveolar lavage, bronchial brush, and endobronchial
biopsy. In: Ernst A. (Ed). Introduction to Bronchoscopy. Cambridge University Press; 2009.
p.85-97
5. Kasuma D. Profil penderita yang dilakukan tindakan bronkoskopi serat optik lentur di
instalasi
diagnostik
terpadu
(IDT)
RSUP
H.
Adam
Malik
Medan.
http://repository.usu.ac.id/handle/123456789/17044. Diunduh pada tanggal 11 September
2012; 11.21 AM
6. Chang HH, Dreyfuss JM, Ramoni MF. A transcriptional network signature characterizes lung
cancer subtypes. Cancer. 2011 January 15; 117(2): 353–60. Diunduh pada tanggal 16 April
2012; 5.25 PM
7. Stenhouse G, Fyfe N, King G, Chapman A, Kerr KM. Thyroid transcription factor 1 in
pulmonary adenocarcinoma. J Clin Pathol. 2004;57:383–7. Diunduh pada tanggal 16 Agustus
2012; 3.30 PM.
8. Kwei KA, Kim YH, Girard L, Kao J, Pacyna-Gengelbach M, Salari K. Genomic profiling
identifies titf1 as a lineage-specific oncogene amplified in lung cancer. Oncogene. 2008; June
5; 27(25): 3635–40. Diunduh pada tanggal 16 Agustus 2012; 3.40 PM
9. Barle´ si F, Pinot D, LeGoffic A, Doddoli C, Chetaille B, Torre V, et al. Positive thyroid
transcription factor 1 staining strongly correlates with survival of patients with
adenocarcinoma of the lung. British Journal of Cancer. 2005; 93: 450-2. Diunduh pada
tanggal 16 April 2012; 4.25 PM
91
Universitas Sumatera Utara
Please purchase 'e-PDF Converter and Creator' on http://www.e-pdfconverter.com to remove this message.
10. Ray MR, Jablons D, He B. Lung cancer therapeutics that target signaling pathways: an
update. Expert Rev Respir Med. 2010 October ; 4(5): 631–45. Diunduh pada tanggal 16
Agustus 2012; 4.46 PM
11. Sadler TW. Respiratory System. In: Langman’s Medical Embryology. 8th Ed. p.278-88
12. Warburton D, El-Hashash A, Carraro G, Tiozzo C, Sala F, Rogers O. Lung organogenesis.
Curr Top Dev Biol. 2010 ; 90: 73–158. doi:10.1016/S0070-2153(10)90003-3. Diunduh pada
tanggal 21Mei 2012; 1.20 PM
13. Ellis H. Clinical Anatomy. 11th ed. Blackwell Publishing Ltd; 2006:19-27
14. Bourke SJ. Anatomy And Physiology of The Lungs. In: Respiratory Medicine. 6th Ed.
Blackwell Publishing Ltd; 2003. p.1-7
15. Tank PW, Gest TR. Lippincott Williams & Wilkins Atlas of Anatomy. 1st Edition.
Lippincott Williams & Wilkins; 2009. p.189-91
16. Jika tidak dikendalikan 26 juta orang di dunia menderita kanker . Pusat Komunikasi Publik,
Sekretariat Jenderal Kementerian Kesehatan RI. 2011. Diunduh dari: http://depkes.go.id.
Diunduh pada tanggal 3 September 2012; 7.31 PM
17. Tyczy ski JE, Parkin DM. Global epidemiology of lung cancer. In: Hirsch FR, Bunn PA,
Kato H, Mulshine JL.(Eds). Textbook of Prevention and Detection of Early Lung Cancer.
Taylor & Francis. 1st Ed; 2006. p.1-18
18. Petersen I. The Morphological and Molecular Diagnosis of Lung Cancer. Dtsch Arztebl Int
2011; 108(31–32):525–31. DOI: 10.3238/arztebl.2011.0525. Diunduh pada tanggal 16 April
2012; 4.56 PM
19. Sleimana M, Gundela LA, Pankowb JF, III PJ, Singera BC, Destaillatsa H. Formation of
carcinogens indoors by surface-mediated reactions of nicotine with nitrous acid, leading to
potential thirdhand smoke hazards. PNAS. 2010;107(15):6576-81. Diunduh pada tanggal 22
Oktober 2012; 04.40 AM
20. Sozzi G, Andriani F, Roz L, Dragani TA, Manenti G, Gariboldi M, et al. Lung
carcinogenesis: biology. In: Hirsch FR, Bunn PA, Kato H, Mulshine JL.(Eds). Textbook of
Prevention and Detection of Early Lung Cancer. Taylor & Francis. 1st Ed.;2006. p.96-123.
21. Brambilla E, Gazdar A. Pathogenesis of lung cancer signaling pathways: roadmap for
therapies. Eur Respir J. 2009 June ; 33(6): 1485– 97. doi:10.1183/09031936.00014009.
Diunduh pada tanggal 16 April 2012; 05.09 PM
92
Universitas Sumatera Utara
Please purchase 'e-PDF Converter and Creator' on http://www.e-pdfconverter.com to remove this message.
22. Travis W, Nicholson S, Hirsch FR, Pugatch B, Geisinger K, Brambilla E, et al. Small cell
carcinoma. In: Travis WD, Brambilla E, Müller-Hermelink HK, Harris CC. (Eds). World
Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the
Lung, Pleura, Thymus and Heart. IARC Press Lyon; 2004. p.33-6
23. Husain AN, Kumar V. The lung. In: In : Kumar V, Abbas A, Faust N. (Eds.). Robbins and
Cotran’s Pathologic Basis of Disease. 7th ed. Philadelphia: WB Saunders; 2007. p.711-72
24. Melamed MR. Tumors of the lung: conventional cytology and aspiration biopsy In: Koss LG,
Melamed MR.(Eds). Koss’ Diagnostic Cytology and Its Histopathologic Bases. Vol. II. 5th
Ed. Lipincott William & Wilkins; 2006. p.644-83
25. Yoshizawa A, Motoi N, Riely GJ, Sima CS, Gerald WL, Kris MG, et al. Impact Of Proposed
IASLC/ATS/ERS Classification of Lung Adenocarcinoma: Prognostic Subgroups and
Implications for Further Revision of Staging Based on Analysis of 514 Stage I Cases.
Modern Pathology. 2011; 24: 653–64. Diunduh pada tanggal 7 September 2012; 4.04 AM
26. Mackinnon AC, Husain AN. Lung And Pleura.In: Differential Diagnosis In Surgical
Pathology. Gattuso P, Reddy VB, David O, Spitz DJ, Haber MH.(Eds). Elsevier. 2nd ed;
2010. p.261-3
27. Gazdar AF. Should We Continue to Use The Term Non-Small-Cell Lung Cancer? Annals of
Oncology. 2010; 21 (Supplement 7): vii225–9. doi:10.1093/annonc/mdq372. Diunduh pada
tanggal 7 September 2012; 4.42 AM
28. Ohori P, Rami-Porta R, Franks T, Shimosato Y, Matsuno Y, Khoor A. et al.
Adenocarcinoma. In: Travis WD, Brambilla E, Müller-Hermelink HK, Harris CC. (Eds).
World Health Organization Classification of Tumours. Pathology and Genetics of Tumours
of the Lung, Pleura, Thymus and Heart. IARC Press Lyon; 2004. P.37-46
29. Johnston WW, Elson CE. Respiratory tract. In: Bibbo M, Wilbur DC. (Eds). Comprehensive
Cytopathology. 3rd eds Elsevier; 2008.p.332-50
30. Hasegawal C, Nakayama H, Kameda1 Y, Yamada K, Isobe T. Stromal micropapillary
component as a novel unfavorable prognostic factor of lung adenocarcinoma. Diagnostic
Pathology. 2012;7:3. Diunduh pada tanggal 28 Juli 2013; 09.04 PM
31. Ohe M, Yokose1 T, Sakuma Y, Miyagi Y, Okamoto N, Osanai S,Hasegawa1C, et al.
Stromal micropapillary component as a novel unfavorable prognostic factor of lung
adenocarcinoma. Diagnostic Pathology. 2012;7:3. Diunduh pada tanggal 28 Juli 2013; 09.48
PM
93
Universitas Sumatera Utara
Please purchase 'e-PDF Converter and Creator' on http://www.e-pdfconverter.com to remove this message.
32. Barletta JA,Yeap BY,Chirieac LR. The prognostic significance of grading in lung
adenocarcinoma. Cancer. 2010 February 1; 116(3): 659–69. Diunduh pada tanggal 28 Juli
2013; 09.59 PM
33. Solis LM, Behrens C, Raso G, Lin HY, Kadara H, Yuan P, Galindo H, et al. Histologic
patterns and molecular characteristics of lung adenocarcinoma associated with clinical
outcome. Cancer. 2012 June 1; 118(11): 2889–99. Diunduh pada tanggal 28 Juli 2013; 09.55
PM
34. Prudence A. Russell PA, Wainer Z, Wright GM, Daniels M,Conron M,et al. Does lung
adenocarcinoma subtype predict patient survival? a clinicopathologic study based on the
New International Association for the Study of Lung Cancer/American Thoracic Society/
European Respiratory Society International Multidisciplinary Lung Adenocarcinoma
Classification. J Thorac Oncol. 2011;6: 1496–1504. Diunduh pada tanggal 7 September
2012; 4.23 AM
35. Hammar SP, Brambilla C,PugatchB, Geisinger K, Fernandez EA, Vogt P.Squamous cell
carcinoma. In: Travis WD, Brambilla E, Müller-Hermelink HK, Harris CC. (Eds). World
Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the
Lung, Pleura, Thymus and Heart. IARC Press Lyon; 2004.p.28-32
36. Brambilla E, Pugatch B, Geisinger K, Gal A, Sheppard MN, Guinee DG, et al. Large cell
carcinoma. In: Travis WD, Brambilla E, Müller-Hermelink HK, Harris CC. (Eds). World
Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the
Lung, Pleura, Thymus and Heart. IARC Press Lyon; 2004.p.47-52
37. Hirsch FR, Corrin B, Colby TV. Clinical features and staging. In: Travis WD, Brambilla E,
Müller-Hermelink HK, Harris CC. (Eds). World Health Organization Classification of
Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. IARC
Press Lyon; 2004.p.18-21
38. Erasmus JJ, Leung AN. Current concepts in diagnosis and staging of lung cancer. In: J.
Hodler J, von Schulthess GK, Zollikofer Ch.L.(Eds). Diseases of the Heart, Chest & Breast.
Diagnostic Imaging and Interventional Techniques. Springer; 2007.p.3-10
39. Gaspar LE, Schefter T. Non-surgical approaches to early-stage non-small-cell lung cancer
(NSCLC). In: Hirsch FR, Bunn PA, Kato H, Mulshine JL.(Eds). Textbook of Prevention and
Detection of Early Lung Cancer. Taylor & Francis. 1st Ed; 2006.p.312-39
40. Mollberg ,Surati M, Demchuk C, Fathi C,Salama AK, Husain AN.et al. Mind-Mapping for
Lung Cancer: Towards A Personalized Therapeutics Approach. Adv Ther. 2011 March ;
94
Universitas Sumatera Utara
Please purchase 'e-PDF Converter and Creator' on http://www.e-pdfconverter.com to remove this message.
28(3):173–94. doi:10.1007/s12325-010-0103-9. Diunduh pada tanggal 16 Agustus 2012;
4.26 PM
41. Osmon SB, Mayse M. Bronchoscopy. In : Shiffren A, Lin TL.(Eds). The Washington
Manual Subspecialty Consult-Pulmonary Medicine Subspecialty Consult; Lippincott
Williams & Wilkins, Washington USA.2003;4:28-34.
42. Stanzel F, Haussinger K. Fluorescence bronchoscopy. In : Beamis JF, Mehta AC, Mathur
PN. (Eds). Interventional Pulmonary Medicine; Marcel Dekker Inc; New York-USA; 2004
(18): 355-84.
43. Alamoudi OS, Attar SM, Ghabrah TM, Kassimi MA. Bronchoscopy, indications, safety and
complications. Saudi Medical Journal 2000; Vol. 21 (11): 1043-7. Diunduh pada tanggal 11
September 2012; 03.35 PM
44. Heart FJF, Beamis JF, Earnist A. History of rigid bronchoscopy. In : Earnist A, Mathur PN,
Mehta AC. International Pulmonary Medicine; Marcell Dekker Inc; New York-USA; 2004
(1): 1-12
45. Ayers ML, Beamis JF. Rigid Bronchoscopy in The Twenty-Fisrt Century. Clin Chest Med.
2001; 22 (2): 355-63.
46. Prakash UBS, Cavaliere S. Bronchoscopy. In: Gold WM, Murray JF, Nadel JA. Atlas of
Procedures in Respiratory Medicine. Saunders WB Company, Philadelphia-USA; 2002 (6):
241-65.
47. Adali F, Uysal A, Bayramoglu S, Guner NT, Yilmaz G, Cimilli T. Virtual and fiber-optic
bronchoscopy in patients with indication for tracheobronchial evaluation. Ann Thorac Med.
2010 Apr-Jun; 5(2): 104–9. doi: 10.4103/1817-1737.62474. Diunduh pada tanggal 11
September 2012; 03.01 PM
48. Haas AR, Vachani A, Sterman DH. Advances in Diagnostic Bronchoscopy. Am J Respir Crit
Care Med. 2010; 182: 589–97. Diunduh pada tanggal 11 September 2012; 02.51 PM
49. Freitag L, Macha HN. Interventional bronchoscopic procedures. In: Lung cancer. Eur Respir.
2001: 272-304. Diunduh pada tanggal 11 September 2012; 02.35 PM
50. Miyajawa T. History of flexible bronchoscopy. In: Bolliger CT, Mathur PN. Interventional
Bronchoscopy; Kargel-Basel Switzerland; 2000;(30):16-21.
95
Universitas Sumatera Utara
Please purchase 'e-PDF Converter and Creator' on http://www.e-pdfconverter.com to remove this message.
51. Bourke SJ. Carcinoma of the lungs. In: Respiratory Medicine. 6th Ed. Blackwell Publishing
Ltd. 2003:125-35.
52. Travis WD, Rekhtman N, Riley GJ, Geisinger KR, Asamura H, Brambilla E. Pathologic
diagnosis of advanced lung cancer based on small biopsies and cytology: a paradigm shift.
Journal of Thoracic Oncology. 2010; 5: 4. Diunduh pada tanggal 7 September 2012; 03.51
AM
53. Fan YB, Wang QS, Ye L, Wang TY, Wu GP. Clinical application of the surepath liquidbased pap test in cytological screening of bronchial brushing for the diagnosis of lung cancer.
Cytotechnology. 2010; 62:53–9. DOI 10.1007/s10616-010-9261-5. Diunduh pada tanggal 11
September 2012; 03.11 PM
54. Monaco SE, Schuchert MJ, Walid E. Khalbuss WE. Diagnostic difficulties and pitfalls in
rapid on-site evaluation of endobronchial ultrasound guided fine needle aspiration.
Cytojournal. 2010; 7: 9. Diunduh pada tanggal 11 September 2012; 08.08 PM
55. Ganjei-Azar P, Nadji M. Color Atlas of Immunocytochemistry in Diagnostic Cytology.
Springer; 2007.p.1-152
56. Myong NH. Thyroid transcription factor-1 (TTF-1) expression in human lung carcinomas: Its
prognostic implication and relationship with expressions of p53 and KI-67 proteins. J Korean
Med Sci. 2003; 18: 494-500. Diunduh pada tanggal 16 Agustus 2012; 04.10 PM
57. Cardoso WV. Lung morphogenesis, role of growth factors and transcription factors. In:
Richard Harding R, Pinkerton KE, Plopper CG.(Eds).The Lung: Development, Aging and the
Environment. Elsevier; 2004.p.3-12.
58. Kimura S. Thyroid-specific transcription factors and their roles in thyroid cancer. Journal of
Thyroid Research. 2011; (2011): Article ID 710213, 8 pages. doi:10.4061/2011/710213.
Diunduh pada tanggal 16 April 2012; 05.13 PM
59. Abutaily AS, Addis BJ, Roche WR. Immunohistochemistry in the distinction between
malignant mesothelioma and pulmonary adenocarcinoma: a critical evaluation of new
antibodies. J Clin Pathol. 2002;55:662–8. Diunduh pada tanggal 16 Agustus 2012; 03.46 PM
60. Matoso A, Singh K, Jacob R, Greaves WO, Tavares R, Noble L, et al. Comparison of thyroid
transcription factor-1 expression by two monoclonal antibodies in pulmonary and non-
96
Universitas Sumatera Utara
Please purchase 'e-PDF Converter and Creator' on http://www.e-pdfconverter.com to remove this message.
pulmonary primary tumors. Appl Immunohistochem Mol Morphol. 2010 March ; 18(2):
142–9. Diunduh pada tanggal 16 April 2012; 05.23 PM
61. Hecht JL, Pinkus JL, Weinstein LJ, Pinkus GS. The value of thyroid transcription factor-1 in
cytologic preparations as a marker for metastatic adenocarcinoma of lung origin. Am J Clin
Pathol 2001;116:483-8. Diunduh pada tanggal 27 Oktober 2013; 12.06 AM
62. Wu M, Wang B, Gil J, Sabo E, Miller L, Gan L, et al. p63 and TTF-1 immunostaining a
useful marker panel for distinguishing small cell carcinoma of lung from poorly
differentiated squamous cell carcinoma of lung. Am J Clin Pathol 2003;119:696-702.
Diunduh pada tanggal 27 Oktober 2013; 01.57 PM
63. Liu J, Farhood A. Immunostaining for thyroid transcription factor-1 on fine-needle
aspiration specimens of lung tumors. Cancer. 2004; 102: 109–14. Diunduh pada tanggal 28
Oktober 2013; 02.24 AM
64. Liu J, Farhood A. Thyroid transcription factor-1 immunocytochemical staining of pleural
fluid cytocentrifuge preparations for detection of small cell lung carcinoma. Acta Cytol.
2004; 48: 635-40. Diunduh pada tanggal 27 Oktober 2013; 03.29 PM
65. Kalhor N, Zander DS, Liu J. TTF-1 and p63 for distinguishing pulmonary small-cell
carcinoma from poorly differentiated squamous cell carcinoma in previously pap-stained
cytologic material. Modern Pathology.2006;19:1117–23. Diunduh pada tanggal 27 Oktober
2013; 12.16 AM
66. Sastroasmoro, S. Dasar-dasar Metodologi Penelitian Klinis. CV Sagung Seto. Jakarta. 2002.
67. Whithaus K, Fukuoka J, Prihoda TJ, Jagirdar J. Evaluation of napsin A, cytokeratin 5/6, p63,
and thyroid transcription factor 1 in adenocarcinoma versus squamous cell carcinoma of the
lung. Arch Pathol Lab Med. 2012;136:155–62. Diunduh pada tanggal 16 April 2012; 06.08
PM
97
Universitas Sumatera Utara
Please purchase 'e-PDF Converter and Creator' on http://www.e-pdfconverter.com to remove this message.
1. Parkin M, Tyczynski JE, Boffetta P, Samet J, Shields P, Caporaso N. Lung cancer
epidemiology and etiology. In: Travis WD, Brambilla E, Müller-Hermelink HK, Harris CC.
(Eds). World Health Organization Classification of Tumours. Pathology and Genetics of
Tumours of the Lung, Pleura, Thymus and Heart. IARC Press Lyon; 2004.p.14-17
2. French CA. Respiratory Tract. In : Cibas ES, Ducatman BS.(eds). Cytology: Diagnostic
Principles Clinical Correlates. 3rd ed. Elsevier. Philadelphia. 2009; p.89-100
3. Gaur DS, Thapliyal NC, Kishore S, Pathak VP. Efficacy of broncho-alveolar lavage and
bronchial brush cytology in diagnosing lung cancers. Jurnal of Cytology. 2007; 24 (24): 73-7.
Diunduh pada tanggal 3 Pebruari 2010;12.16.PM
4. Lamb C. Bronchial washing, bronchoalveolar lavage, bronchial brush, and endobronchial
biopsy. In: Ernst A. (Ed). Introduction to Bronchoscopy. Cambridge University Press; 2009.
p.85-97
5. Kasuma D. Profil penderita yang dilakukan tindakan bronkoskopi serat optik lentur di
instalasi
diagnostik
terpadu
(IDT)
RSUP
H.
Adam
Malik
Medan.
http://repository.usu.ac.id/handle/123456789/17044. Diunduh pada tanggal 11 September
2012; 11.21 AM
6. Chang HH, Dreyfuss JM, Ramoni MF. A transcriptional network signature characterizes lung
cancer subtypes. Cancer. 2011 January 15; 117(2): 353–60. Diunduh pada tanggal 16 April
2012; 5.25 PM
7. Stenhouse G, Fyfe N, King G, Chapman A, Kerr KM. Thyroid transcription factor 1 in
pulmonary adenocarcinoma. J Clin Pathol. 2004;57:383–7. Diunduh pada tanggal 16 Agustus
2012; 3.30 PM.
8. Kwei KA, Kim YH, Girard L, Kao J, Pacyna-Gengelbach M, Salari K. Genomic profiling
identifies titf1 as a lineage-specific oncogene amplified in lung cancer. Oncogene. 2008; June
5; 27(25): 3635–40. Diunduh pada tanggal 16 Agustus 2012; 3.40 PM
9. Barle´ si F, Pinot D, LeGoffic A, Doddoli C, Chetaille B, Torre V, et al. Positive thyroid
transcription factor 1 staining strongly correlates with survival of patients with
adenocarcinoma of the lung. British Journal of Cancer. 2005; 93: 450-2. Diunduh pada
tanggal 16 April 2012; 4.25 PM
91
Universitas Sumatera Utara
Please purchase 'e-PDF Converter and Creator' on http://www.e-pdfconverter.com to remove this message.
10. Ray MR, Jablons D, He B. Lung cancer therapeutics that target signaling pathways: an
update. Expert Rev Respir Med. 2010 October ; 4(5): 631–45. Diunduh pada tanggal 16
Agustus 2012; 4.46 PM
11. Sadler TW. Respiratory System. In: Langman’s Medical Embryology. 8th Ed. p.278-88
12. Warburton D, El-Hashash A, Carraro G, Tiozzo C, Sala F, Rogers O. Lung organogenesis.
Curr Top Dev Biol. 2010 ; 90: 73–158. doi:10.1016/S0070-2153(10)90003-3. Diunduh pada
tanggal 21Mei 2012; 1.20 PM
13. Ellis H. Clinical Anatomy. 11th ed. Blackwell Publishing Ltd; 2006:19-27
14. Bourke SJ. Anatomy And Physiology of The Lungs. In: Respiratory Medicine. 6th Ed.
Blackwell Publishing Ltd; 2003. p.1-7
15. Tank PW, Gest TR. Lippincott Williams & Wilkins Atlas of Anatomy. 1st Edition.
Lippincott Williams & Wilkins; 2009. p.189-91
16. Jika tidak dikendalikan 26 juta orang di dunia menderita kanker . Pusat Komunikasi Publik,
Sekretariat Jenderal Kementerian Kesehatan RI. 2011. Diunduh dari: http://depkes.go.id.
Diunduh pada tanggal 3 September 2012; 7.31 PM
17. Tyczy ski JE, Parkin DM. Global epidemiology of lung cancer. In: Hirsch FR, Bunn PA,
Kato H, Mulshine JL.(Eds). Textbook of Prevention and Detection of Early Lung Cancer.
Taylor & Francis. 1st Ed; 2006. p.1-18
18. Petersen I. The Morphological and Molecular Diagnosis of Lung Cancer. Dtsch Arztebl Int
2011; 108(31–32):525–31. DOI: 10.3238/arztebl.2011.0525. Diunduh pada tanggal 16 April
2012; 4.56 PM
19. Sleimana M, Gundela LA, Pankowb JF, III PJ, Singera BC, Destaillatsa H. Formation of
carcinogens indoors by surface-mediated reactions of nicotine with nitrous acid, leading to
potential thirdhand smoke hazards. PNAS. 2010;107(15):6576-81. Diunduh pada tanggal 22
Oktober 2012; 04.40 AM
20. Sozzi G, Andriani F, Roz L, Dragani TA, Manenti G, Gariboldi M, et al. Lung
carcinogenesis: biology. In: Hirsch FR, Bunn PA, Kato H, Mulshine JL.(Eds). Textbook of
Prevention and Detection of Early Lung Cancer. Taylor & Francis. 1st Ed.;2006. p.96-123.
21. Brambilla E, Gazdar A. Pathogenesis of lung cancer signaling pathways: roadmap for
therapies. Eur Respir J. 2009 June ; 33(6): 1485– 97. doi:10.1183/09031936.00014009.
Diunduh pada tanggal 16 April 2012; 05.09 PM
92
Universitas Sumatera Utara
Please purchase 'e-PDF Converter and Creator' on http://www.e-pdfconverter.com to remove this message.
22. Travis W, Nicholson S, Hirsch FR, Pugatch B, Geisinger K, Brambilla E, et al. Small cell
carcinoma. In: Travis WD, Brambilla E, Müller-Hermelink HK, Harris CC. (Eds). World
Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the
Lung, Pleura, Thymus and Heart. IARC Press Lyon; 2004. p.33-6
23. Husain AN, Kumar V. The lung. In: In : Kumar V, Abbas A, Faust N. (Eds.). Robbins and
Cotran’s Pathologic Basis of Disease. 7th ed. Philadelphia: WB Saunders; 2007. p.711-72
24. Melamed MR. Tumors of the lung: conventional cytology and aspiration biopsy In: Koss LG,
Melamed MR.(Eds). Koss’ Diagnostic Cytology and Its Histopathologic Bases. Vol. II. 5th
Ed. Lipincott William & Wilkins; 2006. p.644-83
25. Yoshizawa A, Motoi N, Riely GJ, Sima CS, Gerald WL, Kris MG, et al. Impact Of Proposed
IASLC/ATS/ERS Classification of Lung Adenocarcinoma: Prognostic Subgroups and
Implications for Further Revision of Staging Based on Analysis of 514 Stage I Cases.
Modern Pathology. 2011; 24: 653–64. Diunduh pada tanggal 7 September 2012; 4.04 AM
26. Mackinnon AC, Husain AN. Lung And Pleura.In: Differential Diagnosis In Surgical
Pathology. Gattuso P, Reddy VB, David O, Spitz DJ, Haber MH.(Eds). Elsevier. 2nd ed;
2010. p.261-3
27. Gazdar AF. Should We Continue to Use The Term Non-Small-Cell Lung Cancer? Annals of
Oncology. 2010; 21 (Supplement 7): vii225–9. doi:10.1093/annonc/mdq372. Diunduh pada
tanggal 7 September 2012; 4.42 AM
28. Ohori P, Rami-Porta R, Franks T, Shimosato Y, Matsuno Y, Khoor A. et al.
Adenocarcinoma. In: Travis WD, Brambilla E, Müller-Hermelink HK, Harris CC. (Eds).
World Health Organization Classification of Tumours. Pathology and Genetics of Tumours
of the Lung, Pleura, Thymus and Heart. IARC Press Lyon; 2004. P.37-46
29. Johnston WW, Elson CE. Respiratory tract. In: Bibbo M, Wilbur DC. (Eds). Comprehensive
Cytopathology. 3rd eds Elsevier; 2008.p.332-50
30. Hasegawal C, Nakayama H, Kameda1 Y, Yamada K, Isobe T. Stromal micropapillary
component as a novel unfavorable prognostic factor of lung adenocarcinoma. Diagnostic
Pathology. 2012;7:3. Diunduh pada tanggal 28 Juli 2013; 09.04 PM
31. Ohe M, Yokose1 T, Sakuma Y, Miyagi Y, Okamoto N, Osanai S,Hasegawa1C, et al.
Stromal micropapillary component as a novel unfavorable prognostic factor of lung
adenocarcinoma. Diagnostic Pathology. 2012;7:3. Diunduh pada tanggal 28 Juli 2013; 09.48
PM
93
Universitas Sumatera Utara
Please purchase 'e-PDF Converter and Creator' on http://www.e-pdfconverter.com to remove this message.
32. Barletta JA,Yeap BY,Chirieac LR. The prognostic significance of grading in lung
adenocarcinoma. Cancer. 2010 February 1; 116(3): 659–69. Diunduh pada tanggal 28 Juli
2013; 09.59 PM
33. Solis LM, Behrens C, Raso G, Lin HY, Kadara H, Yuan P, Galindo H, et al. Histologic
patterns and molecular characteristics of lung adenocarcinoma associated with clinical
outcome. Cancer. 2012 June 1; 118(11): 2889–99. Diunduh pada tanggal 28 Juli 2013; 09.55
PM
34. Prudence A. Russell PA, Wainer Z, Wright GM, Daniels M,Conron M,et al. Does lung
adenocarcinoma subtype predict patient survival? a clinicopathologic study based on the
New International Association for the Study of Lung Cancer/American Thoracic Society/
European Respiratory Society International Multidisciplinary Lung Adenocarcinoma
Classification. J Thorac Oncol. 2011;6: 1496–1504. Diunduh pada tanggal 7 September
2012; 4.23 AM
35. Hammar SP, Brambilla C,PugatchB, Geisinger K, Fernandez EA, Vogt P.Squamous cell
carcinoma. In: Travis WD, Brambilla E, Müller-Hermelink HK, Harris CC. (Eds). World
Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the
Lung, Pleura, Thymus and Heart. IARC Press Lyon; 2004.p.28-32
36. Brambilla E, Pugatch B, Geisinger K, Gal A, Sheppard MN, Guinee DG, et al. Large cell
carcinoma. In: Travis WD, Brambilla E, Müller-Hermelink HK, Harris CC. (Eds). World
Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the
Lung, Pleura, Thymus and Heart. IARC Press Lyon; 2004.p.47-52
37. Hirsch FR, Corrin B, Colby TV. Clinical features and staging. In: Travis WD, Brambilla E,
Müller-Hermelink HK, Harris CC. (Eds). World Health Organization Classification of
Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. IARC
Press Lyon; 2004.p.18-21
38. Erasmus JJ, Leung AN. Current concepts in diagnosis and staging of lung cancer. In: J.
Hodler J, von Schulthess GK, Zollikofer Ch.L.(Eds). Diseases of the Heart, Chest & Breast.
Diagnostic Imaging and Interventional Techniques. Springer; 2007.p.3-10
39. Gaspar LE, Schefter T. Non-surgical approaches to early-stage non-small-cell lung cancer
(NSCLC). In: Hirsch FR, Bunn PA, Kato H, Mulshine JL.(Eds). Textbook of Prevention and
Detection of Early Lung Cancer. Taylor & Francis. 1st Ed; 2006.p.312-39
40. Mollberg ,Surati M, Demchuk C, Fathi C,Salama AK, Husain AN.et al. Mind-Mapping for
Lung Cancer: Towards A Personalized Therapeutics Approach. Adv Ther. 2011 March ;
94
Universitas Sumatera Utara
Please purchase 'e-PDF Converter and Creator' on http://www.e-pdfconverter.com to remove this message.
28(3):173–94. doi:10.1007/s12325-010-0103-9. Diunduh pada tanggal 16 Agustus 2012;
4.26 PM
41. Osmon SB, Mayse M. Bronchoscopy. In : Shiffren A, Lin TL.(Eds). The Washington
Manual Subspecialty Consult-Pulmonary Medicine Subspecialty Consult; Lippincott
Williams & Wilkins, Washington USA.2003;4:28-34.
42. Stanzel F, Haussinger K. Fluorescence bronchoscopy. In : Beamis JF, Mehta AC, Mathur
PN. (Eds). Interventional Pulmonary Medicine; Marcel Dekker Inc; New York-USA; 2004
(18): 355-84.
43. Alamoudi OS, Attar SM, Ghabrah TM, Kassimi MA. Bronchoscopy, indications, safety and
complications. Saudi Medical Journal 2000; Vol. 21 (11): 1043-7. Diunduh pada tanggal 11
September 2012; 03.35 PM
44. Heart FJF, Beamis JF, Earnist A. History of rigid bronchoscopy. In : Earnist A, Mathur PN,
Mehta AC. International Pulmonary Medicine; Marcell Dekker Inc; New York-USA; 2004
(1): 1-12
45. Ayers ML, Beamis JF. Rigid Bronchoscopy in The Twenty-Fisrt Century. Clin Chest Med.
2001; 22 (2): 355-63.
46. Prakash UBS, Cavaliere S. Bronchoscopy. In: Gold WM, Murray JF, Nadel JA. Atlas of
Procedures in Respiratory Medicine. Saunders WB Company, Philadelphia-USA; 2002 (6):
241-65.
47. Adali F, Uysal A, Bayramoglu S, Guner NT, Yilmaz G, Cimilli T. Virtual and fiber-optic
bronchoscopy in patients with indication for tracheobronchial evaluation. Ann Thorac Med.
2010 Apr-Jun; 5(2): 104–9. doi: 10.4103/1817-1737.62474. Diunduh pada tanggal 11
September 2012; 03.01 PM
48. Haas AR, Vachani A, Sterman DH. Advances in Diagnostic Bronchoscopy. Am J Respir Crit
Care Med. 2010; 182: 589–97. Diunduh pada tanggal 11 September 2012; 02.51 PM
49. Freitag L, Macha HN. Interventional bronchoscopic procedures. In: Lung cancer. Eur Respir.
2001: 272-304. Diunduh pada tanggal 11 September 2012; 02.35 PM
50. Miyajawa T. History of flexible bronchoscopy. In: Bolliger CT, Mathur PN. Interventional
Bronchoscopy; Kargel-Basel Switzerland; 2000;(30):16-21.
95
Universitas Sumatera Utara
Please purchase 'e-PDF Converter and Creator' on http://www.e-pdfconverter.com to remove this message.
51. Bourke SJ. Carcinoma of the lungs. In: Respiratory Medicine. 6th Ed. Blackwell Publishing
Ltd. 2003:125-35.
52. Travis WD, Rekhtman N, Riley GJ, Geisinger KR, Asamura H, Brambilla E. Pathologic
diagnosis of advanced lung cancer based on small biopsies and cytology: a paradigm shift.
Journal of Thoracic Oncology. 2010; 5: 4. Diunduh pada tanggal 7 September 2012; 03.51
AM
53. Fan YB, Wang QS, Ye L, Wang TY, Wu GP. Clinical application of the surepath liquidbased pap test in cytological screening of bronchial brushing for the diagnosis of lung cancer.
Cytotechnology. 2010; 62:53–9. DOI 10.1007/s10616-010-9261-5. Diunduh pada tanggal 11
September 2012; 03.11 PM
54. Monaco SE, Schuchert MJ, Walid E. Khalbuss WE. Diagnostic difficulties and pitfalls in
rapid on-site evaluation of endobronchial ultrasound guided fine needle aspiration.
Cytojournal. 2010; 7: 9. Diunduh pada tanggal 11 September 2012; 08.08 PM
55. Ganjei-Azar P, Nadji M. Color Atlas of Immunocytochemistry in Diagnostic Cytology.
Springer; 2007.p.1-152
56. Myong NH. Thyroid transcription factor-1 (TTF-1) expression in human lung carcinomas: Its
prognostic implication and relationship with expressions of p53 and KI-67 proteins. J Korean
Med Sci. 2003; 18: 494-500. Diunduh pada tanggal 16 Agustus 2012; 04.10 PM
57. Cardoso WV. Lung morphogenesis, role of growth factors and transcription factors. In:
Richard Harding R, Pinkerton KE, Plopper CG.(Eds).The Lung: Development, Aging and the
Environment. Elsevier; 2004.p.3-12.
58. Kimura S. Thyroid-specific transcription factors and their roles in thyroid cancer. Journal of
Thyroid Research. 2011; (2011): Article ID 710213, 8 pages. doi:10.4061/2011/710213.
Diunduh pada tanggal 16 April 2012; 05.13 PM
59. Abutaily AS, Addis BJ, Roche WR. Immunohistochemistry in the distinction between
malignant mesothelioma and pulmonary adenocarcinoma: a critical evaluation of new
antibodies. J Clin Pathol. 2002;55:662–8. Diunduh pada tanggal 16 Agustus 2012; 03.46 PM
60. Matoso A, Singh K, Jacob R, Greaves WO, Tavares R, Noble L, et al. Comparison of thyroid
transcription factor-1 expression by two monoclonal antibodies in pulmonary and non-
96
Universitas Sumatera Utara
Please purchase 'e-PDF Converter and Creator' on http://www.e-pdfconverter.com to remove this message.
pulmonary primary tumors. Appl Immunohistochem Mol Morphol. 2010 March ; 18(2):
142–9. Diunduh pada tanggal 16 April 2012; 05.23 PM
61. Hecht JL, Pinkus JL, Weinstein LJ, Pinkus GS. The value of thyroid transcription factor-1 in
cytologic preparations as a marker for metastatic adenocarcinoma of lung origin. Am J Clin
Pathol 2001;116:483-8. Diunduh pada tanggal 27 Oktober 2013; 12.06 AM
62. Wu M, Wang B, Gil J, Sabo E, Miller L, Gan L, et al. p63 and TTF-1 immunostaining a
useful marker panel for distinguishing small cell carcinoma of lung from poorly
differentiated squamous cell carcinoma of lung. Am J Clin Pathol 2003;119:696-702.
Diunduh pada tanggal 27 Oktober 2013; 01.57 PM
63. Liu J, Farhood A. Immunostaining for thyroid transcription factor-1 on fine-needle
aspiration specimens of lung tumors. Cancer. 2004; 102: 109–14. Diunduh pada tanggal 28
Oktober 2013; 02.24 AM
64. Liu J, Farhood A. Thyroid transcription factor-1 immunocytochemical staining of pleural
fluid cytocentrifuge preparations for detection of small cell lung carcinoma. Acta Cytol.
2004; 48: 635-40. Diunduh pada tanggal 27 Oktober 2013; 03.29 PM
65. Kalhor N, Zander DS, Liu J. TTF-1 and p63 for distinguishing pulmonary small-cell
carcinoma from poorly differentiated squamous cell carcinoma in previously pap-stained
cytologic material. Modern Pathology.2006;19:1117–23. Diunduh pada tanggal 27 Oktober
2013; 12.16 AM
66. Sastroasmoro, S. Dasar-dasar Metodologi Penelitian Klinis. CV Sagung Seto. Jakarta. 2002.
67. Whithaus K, Fukuoka J, Prihoda TJ, Jagirdar J. Evaluation of napsin A, cytokeratin 5/6, p63,
and thyroid transcription factor 1 in adenocarcinoma versus squamous cell carcinoma of the
lung. Arch Pathol Lab Med. 2012;136:155–62. Diunduh pada tanggal 16 April 2012; 06.08
PM
97
Universitas Sumatera Utara
Please purchase 'e-PDF Converter and Creator' on http://www.e-pdfconverter.com to remove this message.